Author

W. Lima

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

Predictors of four versus six cycles of adjuvant docetaxel–cyclophosphamide in hormone receptor-positive early breast cancer

Introduction: Docetaxel and cyclophosphamide (TC) are a commonly used anthracycline-free regimen for hormone receptor-positive (HR+) early-stage breast cancer. Although typically administered for four to six cycles, the optimal number remains uncertain. Objective: To identify clinical and pathological factors associat...

W. Lima, Rafaela Lopes da Silva Naves, R. Bonadio et al. · Mastology · 0 citations

Open access 2026

The relationship between tumor-infiltrating lymphocytes, pathologic complete response, and event-free survival in patients with early-stage triple-negative breast cancer treated with the KEYNOTE-522 regimen in a real-world scenario

Introduction: Tumor-infiltrating lymphocytes (TILs) are established prognostic and predictive biomarkers in early-stage triple-negative breast cancer (eTNBC). The addition of pembrolizumab to neoadjuvant chemotherapy (NAC) improves outcomes, as demonstrated in the KEYNOTE-522 trial. The role of TILs in this setting war...

R. Bonadio, M. Monteiro, W. Lima et al. · Mastology · 0 citations

Open access 2026

Papillary breast cancer: therapeutic and prognostic real-world data on a rare histologic type

Introduction: Papillary carcinoma is classified as a special subtype of breast neoplasm with an estimated incidence of 0.5% to 1.7% of all invasive breast carcinomas. Due to its rarity, treatment for these tumors is generally based on extrapolation from data on non-special tumor types. Objective: This study aimed to d...

W. Lima, Iara Garcia Nakashima, Y. Reis et al. · Mastology · 0 citations